Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Bobik

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Circulation|August 13, 2008
Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolismAlex Bobik
Journal of Hypertension|April 26, 2003
Intracellular signalling pathways regulating vascular NAD(P)H oxidase and hypertension: an opportunity for development of novel antihypertensive agents?Alex Bobik
Journal of Hypertension|June 18, 2004
Hypertension, transforming growth factor-beta, angiotensin II and kidney diseaseAlex Bobik
Journal of Hypertension|May 6, 2004
Aspirin, superoxide anions and development of hypertensionAlex Bobik
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2006
Transforming growth factor-betas and vascular disordersAlex Bobik
Journal of Hypertension|July 9, 2005
The structural basis of hypertension: vascular remodelling, rarefaction and angiogenesis/arteriogenesisAlex Bobik
Atherosclerosis|December 30, 2011
HMGB1 signals danger in acute coronary syndrome: emergence of a new risk marker for cardiovascular death?Karlheinz Peter, Alex Bobik
Journal of Leukocyte Biology|October 15, 2019
Low Tregs: A targetable risk factor for life-threatening cardiovascular complications after major noncardiac surgeryTin Kyaw, Alex Bobik
Journal of Hypertension|April 7, 2021
Is angiogenic CD4+ T-cell mediated inflammation responsible for endothelial dysfunction in essential hypertension?Tin Kyaw, Alex Bobik
Current Hypertension Reports|November 5, 2003
Metalloproteinases and plasminogen activators in vessel remodelingAlex Bobik, Vselovod Tkachuk
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Circulation|August 13, 2008
Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolismAlex Bobik
Journal of Hypertension|April 26, 2003
Intracellular signalling pathways regulating vascular NAD(P)H oxidase and hypertension: an opportunity for development of novel antihypertensive agents?Alex Bobik
Journal of Hypertension|June 18, 2004
Hypertension, transforming growth factor-beta, angiotensin II and kidney diseaseAlex Bobik
Journal of Hypertension|May 6, 2004
Aspirin, superoxide anions and development of hypertensionAlex Bobik
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2006
Transforming growth factor-betas and vascular disordersAlex Bobik
Journal of Hypertension|July 9, 2005
The structural basis of hypertension: vascular remodelling, rarefaction and angiogenesis/arteriogenesisAlex Bobik
Atherosclerosis|December 30, 2011
HMGB1 signals danger in acute coronary syndrome: emergence of a new risk marker for cardiovascular death?Karlheinz Peter, Alex Bobik
Journal of Leukocyte Biology|October 15, 2019
Low Tregs: A targetable risk factor for life-threatening cardiovascular complications after major noncardiac surgeryTin Kyaw, Alex Bobik
Journal of Hypertension|April 7, 2021
Is angiogenic CD4+ T-cell mediated inflammation responsible for endothelial dysfunction in essential hypertension?Tin Kyaw, Alex Bobik
Current Hypertension Reports|November 5, 2003
Metalloproteinases and plasminogen activators in vessel remodelingAlex Bobik, Vselovod Tkachuk
Pageof 8